News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Rates of guideline-concordant postoperative RAI therapy in well-differentiated thyroid cancer – SSO
Society of Surgical Oncology/X
Jan 10, 2025, 05:49

Rates of guideline-concordant postoperative RAI therapy in well-differentiated thyroid cancer – SSO

Society of Surgical Oncology (SSO) shared a post on X:

“This SOI Article episode of SurgOnc Today features Dr. Heather Wachtel and Sara Ginzberg discussing rates of guideline-concordant postoperative radioactive iodine therapy in patients with well-differentiated thyroid cancer across six hospitals.”

Read further.

More posts featuring Society of Surgical Oncology.

cancer Heather Wachtel OncoDaily Oncology radioactive iodine therapy Sara Ginzberg Society of Surgical Oncology SurgOnc Today thyroid cancer
Special Coverage
Blog
Jan 10, 2025, 05:49
Rates of guideline-concordant postoperative RAI therapy in well-differentiated thyroid cancer - SSO
Blog
Jan 10, 2025, 05:46
Akhil Santhosh: Maintenance chemo's role is questionable with chemo-IO combinations in advanced BTC
Science
Jan 10, 2025, 05:40
Article of the Week, Suggested by the BPDCN International Registry
Career
Jan 10, 2025, 05:39
OncoInfluencers to Follow on Social Media: Gregg Margolis
Blog
Jan 9, 2025, 17:18
Fumiko Ladd Chino: 2025  ASCO JCO Journals Editorial Fellow Application is OPEN
Insight
Jan 9, 2025, 17:18
Jessica MacIntyre: Excited for this year’s 50th Annual Oncology Nursing Society Congress
Blog
Jan 9, 2025, 17:04
Mehdi Hamadani: Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide
Blog
Jan 9, 2025, 16:48
Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects
Blog
Jan 9, 2025, 16:41
Elisabetta Munzone: Harmonizing EHRs in Italy for Better Healthcare Outcomes and Cost Reduction
Blog
Jan 9, 2025, 16:38
Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
Blog
Jan 9, 2025, 16:35
Ahmed Kotb: Ph-like ALL Signaling Pathways and Targets
Blog
Jan 9, 2025, 16:32
Priorities of ESTRO for engagement within the EURAMED framework